Literature DB >> 21791466

Variants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the disease.

Catherine Badens1, Philippe Joly, Imane Agouti, Isabelle Thuret, Katia Gonnet, Synda Fattoum, Alain Francina, Marie-Claude Simeoni, Anderson Loundou, Serge Pissard.   

Abstract

A cohort of 106 patients included in the French National Registry for Thalassemia were genotyped for 5 genetic modifiers of severity: i) β-thalassemia mutations; (ii) the XmnI SNP; (iii) the -3.7 kb α-thal deletion; (iv) the tag-SNP rs 11886868 in BCL11A exon 2; and (v) the tag-SNP rs9399137 in the HBSB1L-cMYB inter-region. Multivariate analysis was performed to study the risk of thalassemia Intermedia phenotype associated with the different combinations of alleles. The presence or absence of the favorable alleles could accurately predict the type of thalassemia in 83.2% of the cases. The percentage of correct predictions made from the β-thalassemia mutations and the XmnI SNP alone were significantly improved by the adjustment with the 3 other modifiers; from 73.6% to 83.2% (P<0.001). In this study, we showed that predictions based on genetic modifiers can foresee the Major or Intermedia type of β-thalassemia, even in cohorts of patients with various β-globin genotypes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21791466      PMCID: PMC3208691          DOI: 10.3324/haematol.2011.046748

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  14 in total

1.  The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.

Authors:  C-C So; Y-Q Song; S T Tsang; L-F Tang; A Y Chan; E S Ma; L-C Chan
Journal:  J Med Genet       Date:  2008-08-12       Impact factor: 6.318

2.  Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation.

Authors:  Geneviève Galarneau; Cameron D Palmer; Vijay G Sankaran; Stuart H Orkin; Joel N Hirschhorn; Guillaume Lettre
Journal:  Nat Genet       Date:  2010-11-07       Impact factor: 38.330

3.  The -158 site 5' to the G gamma gene and G gamma expression.

Authors:  D Labie; O Dunda-Belkhodja; F Rouabhi; J Pagnier; A Ragusa; R L Nagel
Journal:  Blood       Date:  1985-12       Impact factor: 22.113

4.  DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.

Authors:  Guillaume Lettre; Vijay G Sankaran; Marcos André C Bezerra; Aderson S Araújo; Manuela Uda; Serena Sanna; Antonio Cao; David Schlessinger; Fernando F Costa; Joel N Hirschhorn; Stuart H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

5.  A rare example that coinheritance of a severe form of beta-thalassemia and alpha-thalassemia interact in a "synergistic" manner to balance the phenotype of classic thalassemic syndromes.

Authors:  Emmanuel Kanavakis; Joanne Traeger-Synodinos; Stelios Lafioniatis; Christina Lazaropoulou; Theodora Liakopoulou; George Paleologos; Anna Metaxotou-Mavrommati; Alexandra Stamoulakatou; Ioannis Papassotiriou
Journal:  Blood Cells Mol Dis       Date:  2004 Mar-Apr       Impact factor: 3.039

Review 6.  Genetic modifiers of the beta-haemoglobinopathies.

Authors:  Swee Lay Thein
Journal:  Br J Haematol       Date:  2008-05       Impact factor: 6.998

7.  Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia.

Authors:  Manuela Uda; Renzo Galanello; Serena Sanna; Guillaume Lettre; Vijay G Sankaran; Weimin Chen; Gianluca Usala; Fabio Busonero; Andrea Maschio; Giuseppe Albai; Maria Grazia Piras; Natascia Sestu; Sandra Lai; Mariano Dei; Antonella Mulas; Laura Crisponi; Silvia Naitza; Isadora Asunis; Manila Deiana; Ramaiah Nagaraja; Lucia Perseu; Stefania Satta; Maria Dolores Cipollina; Carla Sollaino; Paolo Moi; Joel N Hirschhorn; Stuart H Orkin; Gonçalo R Abecasis; David Schlessinger; Antonio Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-01       Impact factor: 11.205

8.  A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15.

Authors:  Stephan Menzel; Chad Garner; Ivo Gut; Fumihiko Matsuda; Masao Yamaguchi; Simon Heath; Mario Foglio; Diana Zelenika; Anne Boland; Helen Rooks; Steve Best; Tim D Spector; Martin Farrall; Mark Lathrop; Swee Lay Thein
Journal:  Nat Genet       Date:  2007-09-02       Impact factor: 38.330

9.  Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults.

Authors:  Swee Lay Thein; Stephan Menzel; Xu Peng; Steve Best; Jie Jiang; James Close; Nicholas Silver; Ageliki Gerovasilli; Chen Ping; Masao Yamaguchi; Karin Wahlberg; Pinar Ulug; Tim D Spector; Chad Garner; Fumihiko Matsuda; Martin Farrall; Mark Lathrop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

10.  Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance.

Authors:  Bernadette Modell; Maren Khan; Matthew Darlison; Mark A Westwood; David Ingram; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2008-09-25       Impact factor: 5.364

View more
  22 in total

1.  Beta-thalassemia: from genotype to phenotype.

Authors:  Fabrice Danjou; Franco Anni; Renzo Galanello
Journal:  Haematologica       Date:  2011-11       Impact factor: 9.941

2.  Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.

Authors:  Fabrice Danjou; Franco Anni; Lucia Perseu; Stefania Satta; Carlo Dessì; Maria Eliana Lai; Paolo Fortina; Marcella Devoto; Renzo Galanello
Journal:  Haematologica       Date:  2012-01-22       Impact factor: 9.941

Review 3.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

4.  Estimation of the difference in HbF expression due to loss of the 5' δ-globin BCL11A binding region.

Authors:  Elyes Slim Ghedira; Laure Lecerf; Emmanuelle Faubert; Bruno Costes; Kamran Moradkhani; Dora Bachir; Frédéric Galactéros; Serge Pissard
Journal:  Haematologica       Date:  2012-07-16       Impact factor: 9.941

5.  Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β0-Thalassemia Families with High Fetal Hemoglobin Levels.

Authors:  Nicoletta Bianchi; Lucia Carmela Cosenza; Ilaria Lampronti; Alessia Finotti; Giulia Breveglieri; Cristina Zuccato; Enrica Fabbri; Giovanni Marzaro; Adriana Chilin; Gioia De Angelis; Monica Borgatti; Cristiano Gallucci; Cecilia Alfieri; Michela Ribersani; Antonella Isgrò; Marco Marziali; Javid Gaziev; Aldo Morrone; Pietro Sodani; Guido Lucarelli; Roberto Gambari; Katia Paciaroni
Journal:  Mol Diagn Ther       Date:  2016-04       Impact factor: 4.074

Review 6.  Molecular basis of β thalassemia and potential therapeutic targets.

Authors:  Swee Lay Thein
Journal:  Blood Cells Mol Dis       Date:  2017-06-20       Impact factor: 3.039

7.  Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.

Authors:  Giulia Pavani; Anna Fabiano; Marine Laurent; Fatima Amor; Erika Cantelli; Anne Chalumeau; Giulia Maule; Alexandra Tachtsidi; Jean-Paul Concordet; Anna Cereseto; Fulvio Mavilio; Giuliana Ferrari; Annarita Miccio; Mario Amendola
Journal:  Blood Adv       Date:  2021-03-09

8.  A genetic score for the prediction of beta-thalassemia severity.

Authors:  Fabrice Danjou; Marcella Francavilla; Franco Anni; Stefania Satta; Franca-Rosa Demartis; Lucia Perseu; Matteo Manca; Maria Carla Sollaino; Laura Manunza; Elisabetta Mereu; Giuseppe Marceddu; Serge Pissard; Philippe Joly; Isabelle Thuret; Raffaella Origa; Joseph Borg; Gian Luca Forni; Antonio Piga; Maria Eliana Lai; Catherine Badens; Paolo Moi; Renzo Galanello
Journal:  Haematologica       Date:  2014-12-05       Impact factor: 9.941

Review 9.  The prevention of thalassemia.

Authors:  Antonio Cao; Yuet Wai Kan
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

Review 10.  Non-transfusion-dependent thalassemias.

Authors:  Khaled M Musallam; Stefano Rivella; Elliott Vichinsky; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.